Launch of Immunization Programs for Human Papillomavirus to Augment Growth of Human Papillomavirus (HPV) Infection Vaccines Market

 


A human papillomavirus infection can be transmitted to different
parts of the body, but the most common way of transmission is through sexual
intercourse. This means that you may pass this virus to your partner, and they
will carry it to another part of their body where s/he may have an outbreak.
However, there are cases where the virus is not transmitted, or only the
carrier of the virus develops an infection and s/he does not transmit it to
another person. This is also known as secondary infection. Often, HPV infection
doesn’t cause any noticeable symptoms or health problems.

Market Dynamics

High prevalence of cancer is expected to propel growth of the human
papillomavirus (HPV) infection vaccines market. For instance, according to
the American Cancer Society, in 2019, there will be an estimated 1,762,450 new
cancer cases diagnosed and 606,880 cancer deaths in the U.S. Moreover, launch
of immunization programs for human papillomavirus is also expected to aid in
growth of the market. For instance, in December 2019, Cote d’ Ivoire and
Liberia launched the National Immunization Program (NIP) for the
Human-Papillomavirus.

Launch of human papillomavirus tests is expected to offer
lucrative growth opportunities for players in the human papillomavirus (HPV)
infection vaccines market. For instance, in April 2020, F. Hoffmann-La Roche AG
received the U.S. Food and Drug Administration approval for its cobas HPV test
for use on the fully automated, high-throughput cobas 6800/8800 Systems.
Moreover, investment in screening the presence of human papilloma virus is also
expected to aid in growth of the market. For instance, in June 2020, National
Cancer Institute granted US$ 3.1 million to a researcher at Fox Chase Cancer
Center (Pennsylvania, U.S.) for a study evaluating a method that allows Asian
American women to collect their own samples, which can then be tested for the
presence of the human papilloma virus (HPV).

Reluctance to vaccination in several developed and emerging
economies is expected to hinder growth of the human papillomavirus (HPV)
infection vaccines market.

Competitive Analysis  













Major players operating in the human papillomavirus (HPV)
infection vaccines market include, Merck & Co., Inc. and GlaxoSmithKline
plc. The companies having the candidate for HPV vaccines are Shanghai Bovax
Biotechnology Co., Ltd., Profectus BioSciences, Inc., 2A Pharma AB and ISA
Pharmaceuticals.

Comments

Post a Comment

Popular posts from this blog

The Global Gynecological Devices Market Continues To Grow Owing To The Rising Demand For Regular Gynecological Checkups And Increasing Awareness On Women’s Health And Hygiene

Image
  A gynecological device is a medical device that is used to promote female health or to protect and preserve reproductive health for females. This is a very broad category and includes products such as watches, calculators, bandages, and hygienic towels. While many of these products have been clinically tested and found to be safe for female health, there are still a few devices in the market that pose threats to female reproductive health. Gynecological devices are usually fall into three categories: medical devices, biological safety devices, and mechanical devices. Medical devices are those that prevent the risk of injury or trauma to a woman's reproductive organs from medical interventions. Biologic safety devices are those that protect a female's health by promoting female reproductive health. Finally, mechanical devices are those that help maintain a woman's reproductive health and allow her to achieve or reach their desired fertility or pregnancy. The use of any of ...
Read more

Polyethylene Terephthalate Market Continues to Expand as British Petroleum plc signs a cooperation agreement with China Resources Chemical Materials Technology Co. Ltd to strengthen cooperation on PTA sourcing

Image
  PET is an abbreviation for polyethylene terephthalate; the material most often used in PET bottles. PET is an extremely tough plastic, which is why it's commonly used as a packaging material. PET has many advantages over other plastics, including strength, resistance to breaking and crushing, and its natural plasticity it will fill almost anything and is resistant to oil and chemicals that can cause it to break down over time. Rapid growth of the food and beverage industry is expected to drive of the global polyethylene terephthalate market growth . The food and beverage industry has witnessed significant growth in both developed and emerging economies. According to the Food and Drink Federation, the U.K., the food and drink manufacturing sector accounts for 17% in terms of economic contribution. Furthermore, according to the India Brand Equity Foundation (IBEF), the food processing industry contributed 14% of the country’s GDP in 2016. Polyethylene terephthalate or PET is widely...
Read more

Stomach Cancer Drugs Market Continues to Expand as South Korean Drug Manufacturer Celltrion Inc. Receives the WHO Prequalification Standards for its biosimilar

Image
  Stomach cancer is a growth of abnormal tissues that form a tumor in the part of your abdomen. Symptoms of stomach cancer often include persistent abdominal pain, extreme heartburn, extreme vomiting, severe indigestion, abdominal swelling, and frequent diarrhea. These symptoms are common for all forms of stomach cancer but when cancer spreads to the upper part of the chest, the symptoms become far more severe and may eventually cause death. Stomach cancer has the highest survival rate of any type of cancer in the world.  Crocetin (trade name Eulexin) is the first Stomach Cancer Drug that is used in the treatment of gastric cancer. It was later on approved for treating peritoneal mesothelioma but was not marketed extensively due to its negative outcomes at the beginning. Increasing prevalence of stomach cancer is expected to drive growth of the global stomach cancer drugs market during the forecast period. According to the American Cancer Society (ACS), in 2020, around 27,600...
Read more